Abstract
Background
Evidence and guidelines increasingly support an individualised approach to care of people with type 2 diabetes and individualisation of glycaemic targets in response to patient factors.
Methods
We undertook a scoping review of the literature for evidence of factors impacting upon glycated haemoglobin target individualisation in adults with type 2 diabetes. Data were analysed thematically with themes inductively derived from article review.
Findings
Evidence suggests that presence of cardiovascular disease, hypoglycaemia unawareness, severe hypoglycaemia, limited life expectancy, advanced age, long diabetes duration, frailty, cognitive impairment, disability, extensive comorbidity, diabetes distress and patient preference should inform the setting of glycaemic targets.
Conclusions
The management of people with diabetes is complex. In clinical practice, many patients will have a variety of factors that should be considered when personalising their care. Approaches to personalised care and glycaemic treatment targets should be undertaken as part of a shared decision-making process between physician and patient. Use of electronic records
might enable greater efficiency and more widespread use of personalised care plans in diabetes.
Evidence and guidelines increasingly support an individualised approach to care of people with type 2 diabetes and individualisation of glycaemic targets in response to patient factors.
Methods
We undertook a scoping review of the literature for evidence of factors impacting upon glycated haemoglobin target individualisation in adults with type 2 diabetes. Data were analysed thematically with themes inductively derived from article review.
Findings
Evidence suggests that presence of cardiovascular disease, hypoglycaemia unawareness, severe hypoglycaemia, limited life expectancy, advanced age, long diabetes duration, frailty, cognitive impairment, disability, extensive comorbidity, diabetes distress and patient preference should inform the setting of glycaemic targets.
Conclusions
The management of people with diabetes is complex. In clinical practice, many patients will have a variety of factors that should be considered when personalising their care. Approaches to personalised care and glycaemic treatment targets should be undertaken as part of a shared decision-making process between physician and patient. Use of electronic records
might enable greater efficiency and more widespread use of personalised care plans in diabetes.
| Original language | English |
|---|---|
| Pages (from-to) | 257-265 |
| Number of pages | 9 |
| Journal | Clinical Medicine, Journal of the Royal College of Physicians of London |
| Volume | 22 |
| Issue number | 3 |
| Early online date | 20 Apr 2022 |
| DOIs | |
| Publication status | E-pub ahead of print - 20 Apr 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- individualisation
- glycated haemoglobin
- patient factors
- type 2 diabetes
- Diabetes Mellitus, Type 2/drug therapy
- Humans
- Adult
- Blood Glucose
- Glycated Hemoglobin
- Hypoglycemic Agents/therapeutic use
- Hypoglycemia
Fingerprint
Dive into the research topics of 'The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review'. Together they form a unique fingerprint.Student theses
-
Psychometric and biomedical outcomes of setting explicit glycated haemoglobin targets in adults with diabetes: A mixed-methods parallel-group randomised feasibility study
Westall, S. (Author), WATMOUGH, S. (Director of Studies), IRVING, G. (Supervisor) & Narayanan, R. P. (Supervisor), 21 May 2024Student thesis: Doctoral Thesis
File
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver